Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Darou Darman Arang (DDA) is a private Iranian pharmaceutical company specialized in the registration, marketing, and distribution of high-tech medicinal products. Established in 2011, the company focuses on critical therapeutic areas including oncology, hematology, nephrology, and rare diseases, aiming to provide advanced treatment options to the Iranian healthcare market. DDA serves as a strategic partner for international pharmaceutical manufacturers, managing regulatory affairs and supply chain logistics for both finished dosage forms and active pharmaceutical ingredients. The firm is recognized for its expertise in navigating the complex Iranian Food and Drug Administration (IFDA) requirements to ensure the availability of specialized medicines.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Darou darman Arang.